Home
Conference Highlights
View All Conference Highlights
Year in Review / Wrap-Ups
Wrap-Ups
Year in Review
Contact Us
Articles
Articles
Results from RADIANT: Adjuvant Erlotinib in NSCLC
ASCO 2014 – Lung Cancer
Read More ›
Breaking News from the REVEL Study in NSCLC
ASCO 2014 – Lung Cancer
Read More ›
NSCLC Daily News from ASCO 2014: May 30, 2014 – Preview of Key Topics
ASCO 2014 – Lung Cancer
Read More ›
Next-Generation TKIs
ASCO 2014 – Lung Cancer
Read More ›
Value-Based Use of Molecular and Genomic Markers
ASCO 2014 – Lung Cancer
Read More ›
New Results with Existing Agents
ASCO 2014 – Lung Cancer
Read More ›
New Molecular Targets for NSCLC
ASCO 2014 – Lung Cancer
Read More ›
Immune Checkpoint Therapy in NSCLC
ASCO 2014 – Lung Cancer
Read More ›
Prophylactic Cranial Irradiation in the Adjuvant Setting in NSCLC
ASCO 2014 – Lung Cancer
Read More ›
Adjuvant Erlotinib in EGFR-Mutated NSCLC
ASCO 2014 – Lung Cancer
Read More ›
Page 143 of 147
140
141
142
143
144
145
146
Home
Conference Highlights
View All Conference Highlights
Year in Review / Wrap-Ups
Wrap-Ups
Year in Review
Contact Us